With careful attention to a woman’s health, from low-dose imaging to an innovative, interactive approach to mammography — Senographe Essential defines patient experience. GE Healthcare’s flagship digital mammography system is an upgradeable platform designed to deliver clinical confidence and give you what you need to deliver high-quality care. Senographe Essential lets you perform a wide variety of breast procedures from in-office or mobile screening to advanced diagnostic procedures.
Providing expanded performance Starting with a reliable platform upgradeable for advanced applications, the all-in-one Senographe Essential offers remarkable flexibility. Expert services offer the support you need for expanded performance. Extend care with one platform Senographe Essential is designed for screening, diagnostic and interventional procedures. It lets you choose your upgrade path to advanced applications. Starting with screening, the platform is upgradeable to increase its range of capabilities: magnification, stereotaxy, SenoBright* contrast enhanced spectral mammography, and SenoClaire* digital breast tomosynthesis3. High throughput With the industry’s largest field of view4 (24 x 31 cm), Senographe Essential also lets you choose a standard field of view of 19 x 23 cm, allowing you to image a large range of breast sizes. Technologist-focused design allows easy and quick patient positioning: Pre-set gantry positioning enables automatic gantry rotation and quick angle setting. TechInsight functionality provides fast access to priors and gives accurate indications to the technologist regarding breast positioning. Excellent reliability 85% of contracted Senographe Essential detectors installed in 2006 are still in service in 2014.1 The iLinq* system gives you online access to a technical expert, through your equipment console, to solve procedural or processing issue in real time. Delivering clinical confidence Senographe Essential lets you confidently detect and characterize mammo-graphic findings. Every component of your Senographe Essential — from tube, to detector to post-processing — contributes to outstanding image quality. A dual-track X-ray tube (Mo/Rh) delivers an optimal X-ray spectra to penetrate the breast based on breast density and compressed breast thickness. Automatic Optimization of Parameters (AOP) helps you identify the densest breast regions. It automatically selects the appropriate anode, filter, kV and mAs, ensuring repeatable image quality at optimized radiation dose. Breasts differ, and so do clinicians’ viewing preferences. eContrast lets you improve structure visibility for almost any breast type, including implants and stereo images. You can choose among six contrast levels, the setting that optimizes your visual comfort and diagnostic performance. And that’s not all – eContrast improves the image on spot views because the display is optimized for the region under the paddle. An independent conversion detector with a Cesium-Iodide (CsI) scintillator on an amorphous Silicon (a-Si) flat-panel array results in a high DQE (70%2), for efficient imaging at low dose.
Stand out with privileged access to upgrades of Senographe Essential SenoBright contrast enhanced spectral mammography SenoBright is GE Healthcare’s first-in-class tool that combines the quality of digital mammog-raphy with an intravenous injection of iodine. Performed as an adjunct to inconclusive mammography and ultrasound, SenoBright highlights areas of unusual blood flow pat-terns that may be cause for increased suspicion - all in a simple, quick, procedure that takes less than ten minutes - much like a regular mammography exam. Stereotaxy GE Healthcare’s stereotaxy system provides accurate access to the breast lesion and optimal patient positioning. It enables aneasy switch from full-field digital mammography to a stereotactic biopsy mode. SenoClaire digital breast tomosynthesis3 GE Healthcare’s SenoClaire breast tomosynthesis is a 3D imaging technology that uses a low-dose short X-ray sweep around the compressed breast. SenoClaire provides superior sensitivity for architectural distortions and masses, giving more clinical confidence while delivering no more dose than a 2D standard acquisition of the same view. SenoClaire has the potential to replace standard 2-view mammography exams in screening.